Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
EPR Properties
EPR
$4.59B
| $9.42M | ﹤0.01% |
161,624
-61,656
| -28% | -$3.25M |
|
1627
Robert Half
RHI
$4.32B
| $9.42M | ﹤0.01% |
229,365
-192,947
| -46% | -$8.79M |
|
1628
Cavco Industries
CVCO
$4.56B
| $9.4M | ﹤0.01% |
21,639
+5,288
| +32% | +$2.48M |
|
|
CON
1629
Concentra Group Holdings
CON
$4.21B
| $9.4M | ﹤0.01% |
456,849
+290,375
| +174% | +$6.2M |
|
1630
Goodyear
GT
$1.75B
| $9.34M | ﹤0.01% |
900,597
+177,084
| +24% | +$1.88M |
|
1631
SiteOne Landscape Supply
SITE
$4.32B
| $9.34M | ﹤0.01% |
77,201
+36,446
| +89% | +$4.31M |
|
1632
CALL
EQT Corp
EQT
$34B
| $9.33M | ﹤0.01% |
160,000
-545,100
| -77% | -$29.4M |
|
1633
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $9.33M | ﹤0.01% |
112,500
-175,000
| -61% | -$14M |
|
1634
ProShares S&P 500 ex-Financials ETF
SPXN
$80.4M
| $9.27M | ﹤0.01% |
140,000
| – | – |
|
1635
Mercury Insurance
MCY
$5.84B
| $9.27M | ﹤0.01% |
137,659
+11,673
| +9% | +$694K |
|
1636
APi Group
APG
$18.5B
| $9.25M | ﹤0.01% |
271,865
+2,222
| +0.8% | +$63.6K |
|
1637
PUT
Urban Outfitters
URBN
$6.79B
| $9.25M | ﹤0.01% |
+127,500
| New | +$7.66M |
|
1638
Acadia Pharmaceuticals
ACAD
$5.06B
| $9.22M | ﹤0.01% |
427,473
+179,025
| +72% | +$3.33M |
|
|
CSW
1639
CSW Industrials
CSW
$5.71B
| $9.21M | ﹤0.01% |
32,110
+9,912
| +45% | +$2.99M |
|
1640
Pacira BioSciences
PCRX
$972M
| $9.2M | ﹤0.01% |
384,857
+13,080
| +4% | +$330K |
|
1641
SiTime
SITM
$20B
| $9.19M | ﹤0.01% |
43,142
+17,189
| +66% | +$3.11M |
|
|
ACLX
1642
DELISTED
Arcellx
ACLX
| $9.18M | ﹤0.01% |
139,378
+61,739
| +80% | +$3.84M |
|
1643
Seadrill
SDRL
$2.93B
| $9.14M | ﹤0.01% |
348,242
-433,718
| -55% | -$10.2M |
|
1644
Advanced Drainage Systems
WMS
$10.8B
| $9.13M | ﹤0.01% |
79,514
+38,010
| +92% | +$4.26M |
|
1645
Doximity
DOCS
$4.65B
| $9.13M | ﹤0.01% |
148,861
+36,433
| +32% | +$2.03M |
|
1646
Spire
SR
$4.87B
| $9.12M | ﹤0.01% |
124,892
+29,178
| +30% | +$2.18M |
|
|
SFBS
1647
ServisFirst Bancshares
SFBS
$4.89B
| $9.1M | ﹤0.01% |
117,379
+36,685
| +45% | +$2.71M |
|
1648
Eagle Materials
EXP
$6.57B
| $9.05M | ﹤0.01% |
44,787
+2,101
| +5% | +$453K |
|
1649
Enova International
ENVA
$6.42B
| $9.04M | ﹤0.01% |
81,092
+25,132
| +45% | +$2.4M |
|
1650
Outfront Media
OUT
$5.26B
| $9.04M | ﹤0.01% |
553,966
-232,076
| -30% | -$3.63M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.